Your browser doesn't support javascript.
loading
Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.
Takahashi, Kiyohiko; Cho, Kyu Yong; Nakamura, Akinobu; Miya, Aika; Miyoshi, Arina; Yamamoto, Chiho; Nomoto, Hiroshi; Niwa, Hirokatsu; Takahashi, Kiyohito; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Ito, Yoichi M; Atsumi, Tatsuya; Miyoshi, Hideaki.
Afiliação
  • Takahashi K; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Cho KY; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Nakamura A; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Miya A; Kushiro Red Cross Hospital, Kushiro, Japan.
  • Miyoshi A; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Yamamoto C; Tomakomai City Hospital, Tomakomai, Japan.
  • Nomoto H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Niwa H; NIWA Diabetic Care Clinic, Sapporo, Japan.
  • Takahashi K; Takahashi Kiyohito Clinic, Hakodate, Japan.
  • Manda N; Manda Memorial Hospital, Sapporo, Japan.
  • Kurihara Y; Kurihara Clinic, Sapporo, Japan.
  • Aoki S; Aoki Clinic, Sapporo, Japan.
  • Ito YM; Department of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Miyoshi H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
J Diabetes Investig ; 10(2): 429-438, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30136403
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Tiofenos / Peso Corporal / Índice de Massa Corporal / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Tiofenos / Peso Corporal / Índice de Massa Corporal / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article